Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

526 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A standardized pig model of total hepatectomy for testing liver support systems.
Vistoli F, Boggi U, Bellini R, Colizzi L, Kusmic C, Burchielli S, Campani D, Gneri C, Trivella MG, Filipponi F, Mosca F. Vistoli F, et al. Among authors: boggi u. Transplant Proc. 2000 Dec;32(8):2723-5. doi: 10.1016/s0041-1345(00)01855-8. Transplant Proc. 2000. PMID: 11134775 No abstract available.
Technical problems with a model of ex vivo liver perfusion in the pig.
Boggi U, Bellini R, Vistoli F, Capellini S, Kusmic C, Campani D, Barbieri U, Sartucci F, Burchielli S, Trivella MG, Filipponi F, Mosca F. Boggi U, et al. Transplant Proc. 2000 Dec;32(8):2726-9. doi: 10.1016/s0041-1345(00)01856-x. Transplant Proc. 2000. PMID: 11134776 No abstract available.
Multirow CT in the follow-up of pancreas transplantation.
Neri E, Cappelli C, Boggi U, Salvatori L, Vistoli F, Del Chiaro M, Coletti L, Mosca F, Bartolozzi C. Neri E, et al. Among authors: boggi u. Transplant Proc. 2004 Apr;36(3):597-600. doi: 10.1016/j.transproceed.2004.02.044. Transplant Proc. 2004. PMID: 15110605
Antiangiogenic versus cytotoxic therapeutic approaches to human pancreas cancer: an experimental study with a vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and gemcitabine.
Bocci G, Danesi R, Marangoni G, Fioravanti A, Boggi U, Esposito I, Fasciani A, Boschi E, Campani D, Bevilacqua G, Mosca F, Del Tacca M. Bocci G, et al. Among authors: boggi u. Eur J Pharmacol. 2004 Sep 13;498(1-3):9-18. doi: 10.1016/j.ejphar.2004.07.062. Eur J Pharmacol. 2004. PMID: 15363970
526 results